Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Common medication method for treating retinal artery and vein occlusion

An arteriovenous and retinal technology, applied in the field of medical drugs, can solve the problems of unsatisfactory treatment effect of retinal arteriovenous occlusion, achieve the effect of not strict time requirement, dissolve thrombus, and be convenient to use

Inactive Publication Date: 2017-04-26
李明儒
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Conventional treatment for retinal arteriovenous occlusion is unsatisfactory

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0007] A preferred embodiment of a commonly used medicinal method for treating retinal arteriovenous occlusion of the present invention will be described in detail below.

[0008] The commonly used medicinal method for the treatment of retinal arteriovenous occlusion is oral administration of dextromethorphan, once every 8 hours, 10 mg to 30 mg each time, 7 times a course of treatment, continuous use of 3 to 4 courses of treatment can basically cure, and the vision can basically reach normal human level. Dextromethorphan has a good protective effect on retinal ischemia. An excitatory amino acid receptor blocker, dextromethorphan is an NMDA receptor antagonist that reduces the extent of retinal damage and promotes the recovery of retinal neurons.

[0009] The effect of the commonly used medicine for treating retinal arteriovenous occlusion is obviously better than other medicines and methods for treating retinal arteriovenous occlusion. It is convenient to use, has no side ef...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a common medication method for treating retinal artery and vein occlusion, and relates to the field of medical medicines. The common medication method for treating retinal artery and vein occlusion has an obviously better effect than other medicines and methods for treating the retinal artery and vein occlusion. The common medication method has the advantages of convenience in use, no side effects, no strict requirement of the time, effectiveness to patients with advanced retinal artery and vein occlusion, promotion of recovery of retina neuron, and thrombus dissolving and blood vessel blood flow volume increasing effects.

Description

technical field [0001] The invention relates to the field of medical medicines, more specifically, the invention relates to a common medicinal method for treating retinal arteriovenous occlusion. Background technique [0002] Dextromethorphan is the dextro-isomer of morphine levomorphan methyl ether, which exerts central antitussive effect by inhibiting the medullary cough center. As a commonly used medicine for treating cough, dextromethorphan is usually only used to treat colds and coughs, while ignoring other effects of dextromethorphan. [0003] The latest findings show that dextromethorphan has a good therapeutic effect on retinal arteriovenous occlusion. Dextromethorphan has a good protective effect on retinal ischemia. Conventional treatments for retinal arteriovenous occlusion are currently unsatisfactory. Dextromethorphan has achieved good results in clinical trials for the treatment of retinal arteriovenous occlusion. Contents of the invention [0004] The pr...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K31/485A61P27/02A61P7/02
CPCA61K31/485
Inventor 李明儒
Owner 李明儒
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com